Cargando…

Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker

We report the case of an 87-year-old woman with tuberculous pleurisy. She developed adverse effects in the form of thrombocytopenia and gastrointestinal hemorrhage with isoniazid, and thrombocytopenia with linezolid. Her treatment was switched to contezolid plus cycloserine for a 4-week antibiotic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yixin, Ge, Cheng, Zhang, Huan, Liu, Saizhe, Guo, Hongyang, Cui, Junchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380730/
https://www.ncbi.nlm.nih.gov/pubmed/35983297
http://dx.doi.org/10.2147/IDR.S373082
_version_ 1784768934858194944
author Kang, Yixin
Ge, Cheng
Zhang, Huan
Liu, Saizhe
Guo, Hongyang
Cui, Junchang
author_facet Kang, Yixin
Ge, Cheng
Zhang, Huan
Liu, Saizhe
Guo, Hongyang
Cui, Junchang
author_sort Kang, Yixin
collection PubMed
description We report the case of an 87-year-old woman with tuberculous pleurisy. She developed adverse effects in the form of thrombocytopenia and gastrointestinal hemorrhage with isoniazid, and thrombocytopenia with linezolid. Her treatment was switched to contezolid plus cycloserine for a 4-week antibiotic duration, with a favorable outcome.
format Online
Article
Text
id pubmed-9380730
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93807302022-08-17 Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker Kang, Yixin Ge, Cheng Zhang, Huan Liu, Saizhe Guo, Hongyang Cui, Junchang Infect Drug Resist Case Report We report the case of an 87-year-old woman with tuberculous pleurisy. She developed adverse effects in the form of thrombocytopenia and gastrointestinal hemorrhage with isoniazid, and thrombocytopenia with linezolid. Her treatment was switched to contezolid plus cycloserine for a 4-week antibiotic duration, with a favorable outcome. Dove 2022-08-12 /pmc/articles/PMC9380730/ /pubmed/35983297 http://dx.doi.org/10.2147/IDR.S373082 Text en © 2022 Kang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Kang, Yixin
Ge, Cheng
Zhang, Huan
Liu, Saizhe
Guo, Hongyang
Cui, Junchang
Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
title Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
title_full Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
title_fullStr Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
title_full_unstemmed Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
title_short Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
title_sort compassionate use of contezolid for the treatment of tuberculous pleurisy in a patient with a leadless pacemaker
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380730/
https://www.ncbi.nlm.nih.gov/pubmed/35983297
http://dx.doi.org/10.2147/IDR.S373082
work_keys_str_mv AT kangyixin compassionateuseofcontezolidforthetreatmentoftuberculouspleurisyinapatientwithaleadlesspacemaker
AT gecheng compassionateuseofcontezolidforthetreatmentoftuberculouspleurisyinapatientwithaleadlesspacemaker
AT zhanghuan compassionateuseofcontezolidforthetreatmentoftuberculouspleurisyinapatientwithaleadlesspacemaker
AT liusaizhe compassionateuseofcontezolidforthetreatmentoftuberculouspleurisyinapatientwithaleadlesspacemaker
AT guohongyang compassionateuseofcontezolidforthetreatmentoftuberculouspleurisyinapatientwithaleadlesspacemaker
AT cuijunchang compassionateuseofcontezolidforthetreatmentoftuberculouspleurisyinapatientwithaleadlesspacemaker